PIK3CA and head and neck squamous cell carcinoma: The combination of BKM120 with Cetuximab showed synergistic effects in PIK3CA-mutant and wildtype HNSCC cell lines via the downregulation of AKT and induces apoptosis when BKM120 was given after Cetuximab [54, 67].